European Union

BaFin Notice on Cyber Insurance Fluctuation Reserves

The German Federal Financial Supervisory Authority (BaFin) has issued a regulatory notice regarding the formation of fluctuation reserves for standalone cyber insurance. This notice provides guidance on the requirements and implications for insurers offering cyber insurance products, based on industry data from 2020-2024.

BaFin Notice on Cyber Insurance Fluctuation Reserves

Germany's BaFin has issued a notice clarifying conditions for establishing fluctuation reserves for cyber insurance. The notice addresses how the separate profit and loss statement for cyber insurance, effective end of 2025, impacts reserve formation based on a seven-year observation period.

BaFin Warns of VYNEX Trade WhatsApp Group Offers

Germany's financial regulator, BaFin, has issued a warning regarding VYNEX Trade, which is operating unauthorized financial and crypto-asset services through WhatsApp groups and the Lirunex Trading app. The warning highlights potential investment fraud and advises consumers to exercise extreme caution.

BaFin Warns Against Unauthorised Prometheus Investment Alliance Offers

The German Financial Supervisory Authority (BaFin) has issued a warning against Prometheus Investment Alliance (PIA) for allegedly offering unauthorised financial and cryptoasset services. PIA is suspected of deceiving consumers through WhatsApp groups and a website, directing them to trade via the QVTcoinese-Pro app.

BaFin Warns TGI AG Over Missing Prospectus for Investment Services

Germany's BaFin has issued a warning to TGI AG for allegedly offering capital investments without a required prospectus. The company is suspected of offering 'discounted gold purchases' to the public in Germany, which contravenes the German Capital Investment Act. BaFin is seeking information from the public regarding TGI AG's operations.

EMA CHMP Meeting Minutes July 2025

The European Medicines Agency (EMA) has published the minutes from the Committee for Medicinal Products for Human Use (CHMP) meeting held from July 21-24, 2025. The document details discussions and opinions on various medicinal products, including initial applications and re-examinations.

EMA CHMP Meeting Agenda February 2026

The European Medicines Agency (EMA) has published the draft agenda for the Committee for Medicinal Products for Human Use (CHMP) meeting scheduled for February 23-26, 2026. The agenda outlines topics for discussion, including pre-authorisation and post-authorisation procedures for various medicinal products.

Merger Decision M.12287 TPG / Vitality / SoftBank / Cambridge Mobile Telematics

The European Commission has approved the proposed concentration in Case M.12287, involving TPG, Vitality, SoftBank, and Cambridge Mobile Telematics. The decision, adopted under Article 6(1)(b) of the Merger Regulation, signifies non-opposition to the joint control acquisition.

EU Closes State Aid Investigation for Peugeot Investment

The European Commission has closed its formal investigation into State aid concerning a regional investment project for Peugeot Citroën Automóviles España, S.A. The closure follows a withdrawal by the Member State, Spain, and relates to aid under Articles 107 to 109 of the TFEU.

EU Commission Approves Apollo Funds / Lecta Merger

The European Commission has issued a decision granting non-opposition to the proposed concentration between Apollo Funds and Lecta. This decision, made under the EU Merger Regulation, signifies the Commission's approval of the acquisition.